Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL5347437 | 0.98 | GPR3 (0.32) | GPR3HTR2A | |
| Hydrochloric Acid SCHEMBL7641203 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL9412848 | 0.82 | NR3C1 (0.39) | HTR2A | |
| Hydrochloric Acid SCHEMBL7934667 | 0.81 | ADRA2C (0.31) | — | |
| Methane SCHEMBL7942791 | 0.81 | MEN1 (0.30) | — | |
| Hydrochloric Acid SCHEMBL10317705 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL5390988 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL4884694 | 0.76 | — | — | |
| Fluoride Ion SCHEMBL5389097 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL6228371 | 0.75 | NPC1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1880986-B1 | PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBONS, AND LUBRICANT COMPOSITIONS THEREOF | IDEMITSU KOSAN CO (JP) | 2013-03-06 | — | — | EP | disclosed |
| EP-2222723-B1 | METHOD FOR CONTROLLING BIMODAL CATALYST ACTIVITY DURING POLYMERIZATION | UNIVATION TECH LLC (US) | 2013-02-27 | — | — | EP | disclosed |
| US-8373011-B2 | Used in a base oil of lubricant having good low temperature fluidity, low evaporativity, and thermal stability and oxidation stability | IDEMITSU KOSAN CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-8318872-B2 | Method for controlling bimodal catalyst activity during polymerization | UNIVATION TECHNOLOGIES, LLC (US) | 2012-11-27 | — | — | US | disclosed |
| EP-2222723-A2 | METHOD FOR CONTROLLING BIMODAL CATALYST ACTIVITY DURING POLYMERIZATION | Univation Technologies, LLC (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009082451-A2 | METHOD FOR CONTROLLING BIMODAL CATALYST ACTIVITY DURING POLYMERIZATION | UNIVATION TECHNOLOGIES, LLC (US) | 2009-07-02 | — | — | WO | disclosed |
| US-20080146469-A1 | Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition | IDEMITSU KOSAN CO., LTD. (JP) | 2008-06-19 | — | — | US | disclosed |
| EP-1880986-A1 | PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBON COMPOUND, AND LUBRICANT COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-23 | — | — | EP | disclosed |
| EP-1349881-B1 | POLIMERIZATION PROCESS | UNIVATON TECHNOLOGIES LLC (US) | 2007-10-17 | — | — | EP | disclosed |
| EP-1358218-B1 | CONTROL OF SOLUTION CATALYST DROPLETS | UNIVATION TECH LLC (US) | 2006-07-19 | — | — | EP | disclosed |
| EP-0811637-A2 | Method for feeding a liquid catalyst to a fluidized bed polmerization reactor | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0811638-A2 | Process for controlling static in polymerizations utilizing metallocene catalysts | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-12-10 | — | — | EP | disclosed |
| US-5693727-A | INTRODUCING MONOMERS INTO POLYMERIZATION ZONE CONTAINING BED OF GROWING POLYMER PARTICLES, INTRODUCING UNSUPPORTED POLYMERIZATION CATALYST IN LIQUID FORM INTO VESSEL, WITHDRAWING POLYMERIC PRODUCT, UNREACTED MONOMERS, GASES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
| US-5646083-A | Process for the preparation of a bridged metallocene compound as well as a catalyst component and a process for the polymerization of olefins | DSM N.V. (NL) | 1997-07-08 | — | — | US | disclosed |
| EP-0776908-A1 | Catalyst composition having improved comonomer reactivity | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0768320-A1 | Catalyst component and catalyst | NIPPON OIL CO. LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
| US-5476914-A | Highly crystalline; comprising a high percentage of racemic dyads | FINA TECHNOLOGY, INC. (US) | 1995-12-19 | — | — | US | disclosed |
| EP-0530908-A1 | Process for the preparation of a bridged metallocene compound as well as a catalyst component and a process for the polymerization of olefins | DSM N.V. (NL) | 1993-03-10 | — | — | EP | disclosed |
| US-5132381-A | Aluminoxane, Hafnium Metallocene | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-21 | — | — | US | disclosed |
| EP-0387691-A1 | Process for preparing a syndiotactic polyolefin | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146469-A1 | Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition | ALOX15, ALOX12, ALOX15B | GPR3 1117/4885HTR2A 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.